Processa hires Flesher as Chief Operating Officer
Processa Pharmaceuticals named Gregory J. Flesher as its new Chief Operating Officer, effective November 2, 2026. He will receive a $700,000 annual base salary and be eligible for a discretionary performance bonus of up to 60%.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed